Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism | |
Xiong, Zhaoping1,2,3,4; Wang, Dingyan3,4; Liu, Xiaohong1,2,3; Zhong, Feisheng3,4; Wan, Xiaozhe3,4; Li, Xutong3,4; Li, Zhaojun3; Luo, Xiaomin3; Chen, Kaixian1,2,3; Jiang, Hualiang1,2,3 | |
刊名 | JOURNAL OF MEDICINAL CHEMISTRY |
2020-08-27 | |
卷号 | 63期号:16页码:8749-8760 |
ISSN号 | 0022-2623 |
DOI | 10.1021/acs.jmedchem.9b00959 |
通讯作者 | Jiang, Hualiang(hljiang@simm.ac.cn) ; Zheng, Mingyue(myzheng@simm.ac.cn) |
英文摘要 | Hunting for chemicals with favorable pharmacological, toxicological, and pharmacokinetic properties remains a formidable challenge for drug discovery. Deep learning provides us with powerful tools to build predictive models that are appropriate for the rising amounts of data, but the gap between what these neural networks learn and what human beings can comprehend is growing. Moreover, this gap may induce distrust and restrict deep learning applications in practice. Here, we introduce a new graph neural network architecture called Attentive FP for molecular representation that uses a graph attention mechanism to learn from relevant drug discovery data sets. We demonstrate that Attentive FP achieves state-of-the-art predictive performances on a variety of data sets and that what it learns is interpretable. The feature visualization for Attentive FP suggests that it automatically learns nonlocal intramolecular interactions from specified tasks, which can help us gain chemical insights directly from data beyond human perception. |
资助项目 | National Natural Science Foundation of China[81773634] ; National Natural Science Foundation of China[81430084] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China[2018ZX09711002] ; Personalized Medicines.Molecular Signature-based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12050201] ; open fund of state key laboratory of Pharmaceutical Biotechnology, Nanjing University, China[KF-GN-201706] |
WOS关键词 | DATABASE ; QSAR ; HERG |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | AMER CHEMICAL SOC |
WOS记录号 | WOS:000566757500009 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/291060] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Jiang, Hualiang; Zheng, Mingyue |
作者单位 | 1.ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 200031, Peoples R China 2.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China 3.Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 4.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China |
推荐引用方式 GB/T 7714 | Xiong, Zhaoping,Wang, Dingyan,Liu, Xiaohong,et al. Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism[J]. JOURNAL OF MEDICINAL CHEMISTRY,2020,63(16):8749-8760. |
APA | Xiong, Zhaoping.,Wang, Dingyan.,Liu, Xiaohong.,Zhong, Feisheng.,Wan, Xiaozhe.,...&Zheng, Mingyue.(2020).Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism.JOURNAL OF MEDICINAL CHEMISTRY,63(16),8749-8760. |
MLA | Xiong, Zhaoping,et al."Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism".JOURNAL OF MEDICINAL CHEMISTRY 63.16(2020):8749-8760. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论